Cellular and molecular parameters in human renal allograft rejection

Clinical Biochemistry

Volumn 34, Issue 1, 2001, Pages 29-34

  Kamoun, Malek ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adhesion molecules; Allograft rejection; Chemokine receptors; Cytokines; Endothelial cells; Lymphocyte trafficking; T cell costimulation

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 39; HLA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

CELL ACTIVATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENDOTHELIUM CELL; GENE EXPRESSION; GRAFT FAILURE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR;

ANTIGENS, CD40; ANTIGENS, CD80; CD40 LIGAND; GRAFT REJECTION; HLA ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY TRANSPLANTATION; MODELS, BIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0035113847     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00188-0     Document Type: Conference Paper

References (45)

1. Long-term survival
2. Influence of HLA-A, B and DR matching on the outcome of kidney transplant survival in preimmunized patients
3. Mechanisms and management of acute renal allograft rejection
4. Renal transplantation
5. Risk factors for chronic rejection in renal allograft recipients
6. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema
7. Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussion
8. Long-term failure of renal transplants: Adding insult to injury
9. Molecular correlates of human renal allograft rejection
10. Human renal allograft rejection: Molecular characterization
11. Cytokine analysis of human renal allograft aspiration biopsy cultures supernatants predicts acute rejection
12. Transforming growth factor beta signal transduction in the kidney
13. Transforming growth factor beta in tissue fibrosis
14. Molecular analyses of human renal allografts: Differential intragraft gene expression during rejection
15. Intragraft TGF-beta 1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy
16. Biology of TGF-beta in knockout and transgenic mouse models
17. The role of transforming growth factor beta in chronic renal allograft nephropathy
18. The role of T-cell costimulatory activation pathways in transplant rejection
19. Study of lymphocyte costimulatory molecules in renal transplantation
20. The future of organ and tissue transplantation: Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?
21. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
22. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival
23. Chemokines
24. Chemokines-chemotactic cytokines that mediate inflammation
25. The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells
26. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
27. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats
28. Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection
29. The problem of chronic rejection: Influence of leukocyte-endothelial interactions
30. Can graft endothelial cells initiate a host anti-graft immune response?
31. Leukocyte-endothelial adhesion molecules
32. Expression of vascular cell adhesion molecule-1 in kidney allograft rejection
33. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28 mediated CD4(+) T cell alloactivation
34. Anti-HLA antibodies after solid organ transplantation
35. Mapping of dominant HLA-DR determinants recognized via the indirect pathway
36. Intramolecular and intermolecular spreading during the course of organ allograft rejection
37. Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts
38. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
39. Persistent allopeptide reactivity and epitope spreading in chronic rejection
40. Prospects and applicability of molecular diagnosis of allograft rejection
41. HLA-peptide tetrameric complexes
42. Quantitation of antigen-specific CD8+ T-cell responses
43. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes
44. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis